eddy2 Tuesday, 07/24/18 12:06:13 PM Re: None Post # of 116961 https://www.sec.gov/Archives/edgar/data/1022899/000149315218009498/ex99-1.htm One of the biggest benifits to this drug is it’s ability to calm a cow down while in being transported ect. Adrenaline other wise builds up in the animal. Now of course chickens, pigs ect. Are also effected. Adrenaline build up in animals is one of the greatest spoiler of the animal making it very tough. To administer a drug too a animal requires less hurdles and subsequent less R&D costs along with a much faster entry into the market place. This application of a new drug too relieve stress in animals could, maybe be ready for licensing. Hang on and watch the new revenue numbers come out. The new numbers will tell the story. Note all illigite revenue raised by the selling of paper ie: warrants under a class D arrangement purchased by the former listed public interest minus administrative costs for the above mentioned warrants are none dated leaving a convertible offering open that could possibly be filled at a new par value pending future legit revenue from the above mentioned should a deal be made. There is a huge market as due noted by the mice reaction to the drug in the agriculture industry sector. Do your own DD. Never act on information given that isn’t backed up by a 8K SEC filing.